Impact of Early Atrioventricular Nodal Blocker Use Post‐Transcatheter Aortic Valve Replacement
AV nodal blocker use within 48 h following TAVR was not associated with an increased rate of second-degree or higher AVB or PPM placement. These findings suggest that AV nodal blockers may be considered in the immediate post-TAVR period based on risk-benefit assessment.
Authors
- Lindsay Carter (ORCID: https://orcid.org/0000-0002-9627-6823)
- Theresa Kline (ORCID: https://orcid.org/0000-0002-6865-5543)
- Michael D. Lovelace (ORCID: https://orcid.org/0000-0003-2066-3031)
- Zachary Carroll (ORCID: https://orcid.org/0009-0001-6677-4151)
- Jenna C. Edwards (ORCID: https://orcid.org/0009-0008-4943-5191)
- Jack S. Mandel
Institutions
- University of North Carolina at Chapel Hill (US)
Publication Details
- Journal
- Catheterization and Cardiovascular Interventions
- Published
- 2025-11-20
- DOI
- https://doi.org/10.1002/ccd.70357
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00